Viroids and subviral agents

CCHEMISTRY METALLURGY C12Biochemistry C12NMICRO-ORGANISMS OR ENZYMES COMPOSITIONS THEREOF PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS MUTATION OR GENETIC ENGINEERING CULTURE MEDIA

C12N2790/00Viroids and subviral agents

C12N2790/00011Viroids and subviral agents C12N2790/00021Viruses as such C12N2790/00022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes C12N2790/00023Virus like particles [VLP] C12N2790/00031Uses of virus other than therapeutic or vaccine C12N2790/00032Use of virus as therapeutic agent, other than vaccine C12N2790/00033Use of viral protein as therapeutic agent other than vaccine C12N2790/00034Use of virus or viral component as vaccine C12N2790/00041Use of virus, viral particle or viral elements as a vector C12N2790/00042virus or viral particle as vehicle C12N2790/00043viral genome or elements thereof as genetic vector C12N2790/00044Chimeric viral vector comprising heterologous viral elements for production of another viral vector C12N2790/00045Special targeting system for viral vectors C12N2790/00051Methods of production or purification of viral material C12N2790/00052relating to complementing cells and packaging systems for producing virus or viral particles C12N2790/00061Methods of inactivation or attenuation C12N2790/00062by genetic engineering C12N2790/00063by chemical treatment C12N2790/00064by serial passage C12N2790/00071Demonstrated in vivo effect C12N2790/00088For redistribution C12N2790/10011Prions C12N2790/10021Viruses as such C12N2790/10022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes C12N2790/10023Virus like particles [VLP] C12N2790/10031Uses of virus other than therapeutic or vaccine C12N2790/10032Use of virus as therapeutic agent, other than vaccine C12N2790/10033Use of viral protein as therapeutic agent other than vaccine C12N2790/10034Use of virus or viral component as vaccine C12N2790/10041Use of virus, viral particle or viral elements as a vector C12N2790/10042virus or viral particle as vehicle C12N2790/10043viral genome or elements thereof as genetic vector C12N2790/10044Chimeric viral vector comprising heterologous viral elements for production of another viral vector C12N2790/10045Special targeting system for viral vectors C12N2790/10051Methods of production or purification of viral material C12N2790/10052relating to complementing cells and packaging systems for producing virus or viral particles C12N2790/10061Methods of inactivation or attenuation C12N2790/10062by genetic engineering C12N2790/10063by chemical treatment C12N2790/10064by serial passage C12N2790/10071Demonstrated in vivo effect C12N2790/10088For redistribution C12N2790/12011Satellite viruses C12N2790/12021Viruses as such C12N2790/12022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes C12N2790/12023Virus like particles [VLP] C12N2790/12031Uses of virus other than therapeutic or vaccine C12N2790/12032Use of virus as therapeutic agent, other than vaccine C12N2790/12033Use of viral protein as therapeutic agent other than vaccine C12N2790/12034Use of virus or viral component as vaccine C12N2790/12041Use of virus, viral particle or viral elements as a vector C12N2790/12042virus or viral particle as vehicle C12N2790/12043viral genome or elements thereof as genetic vector C12N2790/12044Chimeric viral vector comprising heterologous viral elements for production of another viral vector C12N2790/12045Special targeting system for viral vectors C12N2790/12051Methods of production or purification of viral material C12N2790/12052relating to complementing cells and packaging systems for producing virus or viral particles C12N2790/12061Methods of inactivation or attenuation C12N2790/12062by genetic engineering C12N2790/12063by chemical treatment C12N2790/12064by serial passage C12N2790/12071Demonstrated in vivo effect C12N2790/12088For redistribution C12N2790/14011Viroids C12N2790/14021Viruses as such C12N2790/14022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes C12N2790/14023Virus like particles [VLP] C12N2790/14031Uses of virus other than therapeutic or vaccine C12N2790/14032Use of virus as therapeutic agent, other than vaccine C12N2790/14033Use of viral protein as therapeutic agent other than vaccine C12N2790/14034Use of virus or viral component as vaccine C12N2790/14041Use of virus, viral particle or viral elements as a vector C12N2790/14042virus or viral particle as vehicle C12N2790/14043viral genome or elements thereof as genetic vector C12N2790/14044Chimeric viral vector comprising heterologous viral elements for production of another viral vector C12N2790/14045Special targeting system for viral vectors C12N2790/14051Methods of production or purification of viral material C12N2790/14052relating to complementing cells and packaging systems for producing virus or viral particles C12N2790/14061Methods of inactivation or attenuation C12N2790/14062by genetic engineering C12N2790/14063by chemical treatment C12N2790/14064by serial passage C12N2790/14071Demonstrated in vivo effect C12N2790/14088For redistribution